From the earliest days of the pandemic, it was clear that the COVID-19 disease had a direct negative impact on the survival of patients with cancer, 8 and the pandemic has indirectly had an impact on ...
New research reveals that the number and complexity of cancer clinical trials since 2001 have varied across low- and middle-income countries (LMICs), with economic growth contributing to disparities, ...
Developing nations encounter unique obstacles in the realm of oncology, including a higher incidence of certain cancers, restricted access to early diagnosis and treatment options, and higher ...
Article ‘Count’ and ‘Share’ for European & Developing Countries Clinical Trials Partnership (EDCTP) based on listed parameters only. According to the parameters selected above, there are no articles ...
The FSHD Society, a patient-driven organization advancing research and clinical development in facioscapulohumeral muscular dystrophy (FSHD), SOLVE FSHD, a venture philanthropic organization dedicated ...
Bari Kowal, Senior Vice President, Development Operations & Portfolio Management at Regeneron Clinical trial innovation is a hot topic, but it’s not a new one. The first fully virtual randomized trial ...
(Yicai) April 8 -- Chinese biotech firm UniXell Biotechnology’s new cell therapy for intractable, or hard-to-treat, epilepsy ...
An analysis of 65,061 globally recruiting clinical trials across 186 countries finds that 4,361 studies, equivalent to 6.7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results